PIK3CA gene amplification is frequent in gastric carcinoma (36.4%), thyroid adenocarcinoma (30%), prostatic cancer (28%), ovarian cancer (13.3–29.8%), and cervical carcinoma (9.0–80%). This evidence concerns the gene PIK3CA and ovarian carcinoma.